Contraception
📧 Sign up to get email alerts when something new happens for Contraception.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2022-04-29FDA Approved: CAMRESE LO — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for CAMRESE LO (levonorgestrel/ethinyl estradiol) from Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2022-04-29FDA Approved: KARIVA — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for KARIVA (desogestrel/ethinyl estradiol), maintaining regulatory approval for this combined oral c…
-
FDA approval · 2022-04-29FDA Approved: AVIANE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for AVIANE (levonorgestrel and ethinyl estradiol) from Teva Pharmaceuticals USA, Inc. The approv…
-
FDA approval · 2022-04-29FDA Approved: BRIELLYN — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a supplemental application for BRIELLYN, a generic combined oral contraceptive containing norethindrone and ethinyl estradiol, …
-
FDA approval · 2022-04-29FDA Approved: SPRINTEC — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for SPRINTEC (norgestimate and ethinyl estradiol) from Teva Pharmaceuticals USA, Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2022-04-29FDA Approved: NORGESTIMATE AND ETHINYL ESTRADIOL — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a supplemental application for NORGESTIMATE AND ETHINYL ESTRADIOL from Glenmark Pharmaceuticals, enabling the generic oral cont…
-
FDA approval · 2022-04-29FDA Approved: TRI-LINYAH — Supplemental Application (Northstar Rx LLC)
FDA approved a supplemental application for TRI-LINYAH (norgestimate and ethinyl estradiol) submitted by Northstar Rx LLC.
-
FDA approval · 2022-04-29FDA Approved: KURVELO — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approves a supplemental application for Kurvelo, a combined oral contraceptive containing levonorgestrel and ethinyl estradiol, submitte…
-
FDA approval · 2022-04-29FDA Approved: LEVONORGESTREL AND ETHINYL ESTRADIOL — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved a supplemental application for Levonorgestrel and Ethinyl Estradiol submitted by Lupin Pharmaceuticals, Inc.
-
FDA approval · 2022-04-29FDA Approved: NORTREL 28 DAY — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for Nortrel 28 Day (norethindrone and ethinyl estradiol) from Teva Pharmaceuticals USA, Inc. und…
-
FDA label_change · 2022-04-29FDA Approved: LEVONORGESTREL AND ETHINYL ESTRADIOL — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for Levonorgestrel and Ethinyl Estradiol from Mylan Pharmaceuticals, resulting in updated labeling f…
-
FDA approval · 2022-04-29FDA Approved: JOLESSA — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for JOLESSA (LEVONORGESTREL / ETHINYL ESTRADIOL) from Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2022-04-29FDA Approved: NORTREL 7/7/7 (28 DAY REGIMEN) — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for Nortrel 7/7/7 (28-day regimen), a combined oral contraceptive containing norethindrone and e…
-
FDA approval · 2022-04-29FDA Approved: MICROGESTIN 24 FE — Supplemental Application (Mayne Pharma Inc.)
FDA approved a supplemental application for Microgestin 24 FE (norethindrone acetate/ethinyl estradiol and ferrous fumarate) by Mayne Pharma…
-
FDA approval · 2022-04-29FDA Approved: NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for the norethindrone/ethinyl estradiol/ferrous fumarate oral contraceptive manufactured by Mylan Ph…
-
FDA approval · 2022-04-29FDA Approved: ISIBLOOM — Supplemental Application (Xiromed, LLC.)
The FDA approved a supplemental application for ISIBLOOM, a desogestrel and ethinyl estradiol oral contraceptive from Xiromed, LLC.
-
FDA approval · 2022-04-29FDA Approved: FEMYNOR — Supplemental Application (Amneal Pharmaceuticals NY LLC)
FDA approves a supplemental application for FEMYNOR, a generic oral contraceptive containing norgestimate and ethinyl estradiol, from Amneal…
-
FDA approval · 2022-04-29FDA Approved: BLISOVI 24 FE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved a supplemental application for BLISOVI 24 FE, a combined oral contraceptive containing norethindrone acetate and ethinyl es…
-
FDA approval · 2022-04-29FDA Approved: ETHYNODIOL DIACETATE AND ETHINYL ESTRADIOL — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for Ethynodiol diacetate and ethinyl estradiol by Mylan Pharmaceuticals, a combined oral contracepti…
-
FDA approval · 2022-04-29FDA Approved: TRI-LO-MILI — Supplemental Application (Aurobindo Pharma Limited)
FDA approves a supplemental application for TRI-LO-MILI (norgestimate and ethinyl estradiol) by Aurobindo Pharma Limited.
-
FDA approval · 2022-04-29FDA Approved: TARINA 24 FE — Supplemental Application (Afaxys Pharma, LLC)
FDA approved a supplemental application for Tarina 24 FE, a combination oral contraceptive, to Afaxys Pharma LLC.
-
FDA approval · 2022-04-29FDA Approved: BALZIVA — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for BALZIVA (norethindrone and ethinyl estradiol) from Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2022-04-29FDA Approved: BALCOLTRA — Supplemental Application (Avion Pharmaceuticals)
FDA approved a supplemental application for BALCOLTRA (levonorgestrel and ethinyl estradiol) submitted by Avion Pharmaceuticals.
-
FDA approval · 2022-04-29FDA Approved: NEXTSTELLIS — Supplemental Application (Mayne Pharma)
The FDA approved a supplemental application for Nextstellis (DROSPIRENONE AND ESTETROL) filed by Mayne Pharma.
-
FDA approval · 2022-04-29FDA Approved: FALMINA — Supplemental Application (Northstar Rx LLC)
FDA approved a supplemental application for Falmina, a combined oral contraceptive containing levonorgestrel and ethinyl estradiol, submitte…